Home Business & Finance Roivant Expects FDA to Approve First Major Drug
Business & Finance

Roivant Expects FDA to Approve First Major Drug

Key Points

Roivant Expects FDA to Approve First Major Drug Roivant Chief Executive Officer Matt Gline expects the FDA to approve the launch of a drug used to fight a debilitating skin disease. He says the drug should be on the market by September. He speaks on "Bloomberg Open Interest."

Aug 6th, 2026 Roivant Expects FDA to Approve First Major Drug Roivant Chief Executive Officer Matt Gline expects the FDA to approve the launch of a drug used to fight a debilitating skin disease. He says the drug should be on the market by September. He speaks on "Bloomberg Open Interest."
Roivant Expects FDA (ORG) FDA (ORG) Matt Gline (PERSON)
Originally published by Bloomberg Markets Read original →